Fifth Lane Capital »

Apellis Pharmaceuticals shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Apellis Pharmaceuticals shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $302k 7.5k 40.23

More positions owned by Fifth Lane Capital

C1 Common Stock (CFND)
Perma-fix Environmental Svcs Com New (PESI)
Sbny 5.0 31 Dec 2049 A - P Equities (SBNYL)
A Spac Iii Acquisition Corp Ord Shs Cl A (ASPC)
Brdtla 7.625 31 Dec 2049 A - P Equities (DTLAP)

View all positions for Fifth Lane Capital

Top funds holding Apellis Pharmaceuticals

BlackRock
venBio Select Advisor
Morgan Stanley
State Street Corporation
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
Deep Track Capital
Point72 Asset Management
Rtw Investments
HBK Investments
Suvretta Capital Management
Millennium Management
Geode Capital Management

View all funds holding Apellis Pharmaceuticals